ZTS 175.68 (+0.01%)
US98978V1035Drug ManufacturersDrug Manufacturers - Specialty & Generic

Zoetis (ZTS) Competitor Comparison

We are evaluating the key criteria listed to compare Zoetis (ZTS) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Valuation Rank - ZTS ranking 40 / 54

These are the competitors of Zoetis in the industry Drug Manufacturers - Specialty & Generic ranked by valuation rank
1. Eagle Pharmaceuticals EGRX
0.86
2. Catalent CTLT
0.79
3. Teva Pharmaceutical Industries TEVA
0.79
4. Vifor Pharma G2AB.F
0.79
5. Clever Leaves Holdings CLVR
0.79
6. Ayr Wellness 3KJB.F
0.71
7. Amneal Pharmaceuticals AMRX
0.71
8. Linc LNC
0.71
9. ProPhase Labs PRPH
0.71
10. Phibro Animal Health PAHC
0.71
11. PetIQ PETQ
0.71
12. Universe Pharmaceuticals UPC
0.64
13. Amphastar Pharmaceuticals AMPH
0.64
14. Embecta EMBC
0.64
15. Taro Pharmaceutical Industries TARO
0.64
16. Perrigo PRGO
0.64
17. Procaps Group PROC
0.64
18. Alimera Sciences ALIM
0.57
19. Alpha Teknova TKNO
0.57
20. Collegium Pharmaceutical COLL
0.57
21. Elanco Animal Health ELAN
0.57
22. Jupiter Wellness JUPW
0.57
23. Kolinpharma KIP.MI
0.57
24. Organogenesis Holdings ORGO
0.57
25. Tilray Brands TLRY
0.57
26. Cronos Group CRON
0.5
27. Ascend Wellness Holdings AAWH
0.5
28. Ironwood Pharmaceuticals IRWD
0.5
29. Regencell Bioscience Holdings RGC
0.5
30. Solid Biosciences SLDB
0.5
31. Emergent BioSolutions EBS
0.5
32. Neoleukin Therapeutics NLTX
0.5
33. Evolus EOLS
0.5
34. Green Thumb Industries R9U2.F
0.5
35. Kamada KMDA
0.5
36. Curaleaf Holdings CURLF
0.5
37. Flora Growth FLGC
0.5
38. Bausch Health Companies BHC
0.43
39. Journey Medical DERM
0.43
40. Zoetis ZTS
0.43
41. Pacira BioSciences PCRX
0.43
42. Cumberland Pharmaceuticals CPIX
0.43
43. Societal CDMO SCTL
0.43
44. Theratechnologies THTX
0.43
45. Relmada Therapeutics RLMD
0.36
46. OptiNose OPTN
0.36
47. ANI Pharmaceuticals ANIP
0.36
48. Alvotech ALVO
0.29
49. Supernus Pharmaceuticals SUPN
0.29
50. Harrow Health HROW
0.29
51. Biofrontera BFRI
0.21
52. SCYNEXIS SCYX
0.07
53. Zynerba Pharmaceuticals ZYNE
0.07
54. Avadel Pharmaceuticals AVDL
0.07

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.